Compare ENS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENS | CRL |
|---|---|---|
| Founded | 1991 | 1947 |
| Country | United States | United States |
| Employees | 9200 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.6B |
| IPO Year | 2004 | 1999 |
| Metric | ENS | CRL |
|---|---|---|
| Price | $220.94 | $215.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $193.00 | ★ $198.27 |
| AVG Volume (30 Days) | 480.6K | ★ 752.4K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.70 | N/A |
| Revenue | $216,125,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $4.49 | N/A |
| Revenue Next Year | $3.41 | $3.04 |
| P/E Ratio | $29.44 | ★ N/A |
| Revenue Growth | ★ 15.85 | 10.48 |
| 52 Week Low | $85.00 | $144.26 |
| 52 Week High | $244.30 | $228.88 |
| Indicator | ENS | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 73.04 |
| Support Level | $215.85 | $193.41 |
| Resistance Level | $241.08 | $228.64 |
| Average True Range (ATR) | 9.88 | 7.45 |
| MACD | -1.64 | 2.68 |
| Stochastic Oscillator | 16.38 | 92.13 |
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, New Ventures, and Specialty.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.